Nanoscale Mobility of the Apo State and TARP Stoichiometry Dictate the Gating Behavior of Alternatively Spliced AMPA Receptors.


Journal

Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320

Informations de publication

Date de publication:
05 06 2019
Historique:
received: 13 12 2018
revised: 08 03 2019
accepted: 28 03 2019
pubmed: 6 5 2019
medline: 24 3 2020
entrez: 5 5 2019
Statut: ppublish

Résumé

Neurotransmitter-gated ion channels are allosteric proteins that switch on and off in response to agonist binding. Most studies have focused on the agonist-bound, activated channel while assigning a lesser role to the apo or resting state. Here, we show that nanoscale mobility of resting α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type ionotropic glutamate receptors (AMPA receptors) predetermines responsiveness to neurotransmitter, allosteric anions and TARP auxiliary subunits. Mobility at rest is regulated by alternative splicing of the flip/flop cassette of the ligand-binding domain, which controls motions in the distant AMPA receptor N-terminal domain (NTD). Flip variants promote moderate NTD movement, which establishes slower channel desensitization and robust regulation by anions and auxiliary subunits. In contrast, greater NTD mobility imparted by the flop cassette acts as a master switch to override allosteric regulation. In AMPA receptor heteromers, TARP stoichiometry further modifies these actions of the flip/flop cassette generating two functionally distinct classes of partially and fully TARPed receptors typical of cerebellar stellate and Purkinje cells.

Identifiants

pubmed: 31053408
pii: S0896-6273(19)30335-6
doi: 10.1016/j.neuron.2019.03.046
pii:
doi:

Substances chimiques

Membrane Proteins 0
Protein Isoforms 0
Receptors, AMPA 0
glutamate receptor ionotropic, AMPA 2 P6W5IXV8V9
glutamate receptor ionotropic, AMPA 1 TFZ3H25BS1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

976-992.e5

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

G Brent Dawe (GB)

Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 2B4, Canada; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Md Fahim Kadir (MF)

Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK.

Raminta Venskutonytė (R)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.

Amanda M Perozzo (AM)

Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 2B4, Canada; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Yuhao Yan (Y)

Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 2B4, Canada; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Ryan P D Alexander (RPD)

Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 2B4, Canada; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Camilo Navarrete (C)

Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK; Department of Physiology, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.

Eduardo A Santander (EA)

Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK.

Marika Arsenault (M)

Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Christian Fuentes (C)

Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK; Department of Physiology, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.

Mark R P Aurousseau (MRP)

Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Karla Frydenvang (K)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.

Nelson P Barrera (NP)

Department of Physiology, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.

Jette S Kastrup (JS)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.

J Michael Edwardson (JM)

Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK.

Derek Bowie (D)

Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada. Electronic address: derek.bowie@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH